African-American women with type 2 diabetes may have higher risk for ER-neg breast cancer

November 15, 2017, American Association for Cancer Research

Among African-American women, those with type 2 diabetes may have a higher risk of developing estrogen receptor (ER)-negative breast cancer.

The study was published in Cancer Research, a journal of the American Association for Cancer Research, by Julie R. Palmer, ScD, associate director of Boston University's Slone Epidemiology Center, professor of epidemiology at Boston University School of Public Health, and associate director for population sciences at the BU-BMC Cancer Center

The majority of cancers are ER-positive; this type of breast cancer is the easiest to treat and has the highest survival rate. African-American women are disproportionally affected by ER-negative breast cancers, with double the incidence as compared to , said Palmer.

"We are still trying to understand the basic biological processes that lead to ER-negative breast cancer. One way to do this is to study factors that are more common in an African-American population," added Palmer.

Several studies suggest that is a risk factor for breast cancer, and type 2 diabetes is twice as prevalent in African-American women as compared to white women, commented Palmer. One previous study analyzed the association with type 2 diabetes and breast cancer in African- American women, but did not report results separately for ER-negative and ER-positive breast cancer.How the Study Was Conducted: The analyses conducted by Palmer and colleagues were based on information provided by participants in the Black Women's Health Study (BWHS). The BWHS was established over 20 years ago and utilizes biennial questionnaires to obtain information from 59,000 African- American women from across the United States. Using this large data set, Palmer and colleagues could control for many factors, including age and body mass index (BMI).

"Our results showed statistically significant evidence of an increased risk of ER-negative breast cancer in black women who had type 2 diabetes before they ever had breast cancer, primarily in the women who had diabetes for at least five years,"said Palmer. They did not find an association with ER-positive breast cancer in the same cohort. Importantly, the association between type 2 diabetes and ER-negative breast cancer was observed only among women with lower BMI (<30). This suggests that abnormal metabolic status may play a larger role in ER-negative breast cancer than obesity, Palmer said.

"Our findings may account for some of the racial disparity in breast cancer, and could partly explain why mortality from breast cancer is so much higher in black women than white ," said Palmer. She stressed that further work is needed to corroborate these relatively new findings. "If these results are confirmed, type 2 diabetes would be a modifiable risk factor for ER-negative breast cancer," noted Palmer. "Women could reduce their chances of getting ER-negative breast cancer if they could avoid developing type 2 diabetes. Monitoring of blood sugar levels to identify pre-diabetes may allow for early interventions to prevent diabetes." Palmer's future work includes testing if diabetes medication, such as metformin, could lower the risk for ER-negative breast .

Limitations of the study include a dependence on self-reports rather than medical records for classification of type 2 diabetes status. Additionally, due to the relatively small sample size in specific subgroups, there was a lack of statistical power for the analysis of medication use.

Explore further: Type 2 diabetes associated with risk of aggressive breast cancer in black women

Related Stories

Type 2 diabetes associated with risk of aggressive breast cancer in black women

November 15, 2017
African American women with type 2 diabetes (often referred to as adult-onset diabetes) are at a greater risk for developing breast cancer.

Childbearing may increase risk of hormone receptor-negative breast cancer in African-American women

August 16, 2011
African-American women are at higher risk for hormone receptor-negative breast cancer, one of the most difficult subtypes to treat, but this risk could be ameliorated somewhat by breast-feeding their children.

Researchers identify breast cancer risk factors for younger, black women

October 19, 2016
Black women under the age of 45 are at increased risk for an aggressive form of breast cancer [estrogen receptor (ER) negative] if they experienced a high number of pregnancies, never breast fed, and/or had higher waist-to-hip ...

Lactation linked to reduced estrogen receptor-negative, triple-negative breast cancer risk

September 16, 2014
Women who have had children (parous women) appear to have an increased risk of developing estrogen receptor-negative breast cancer, the subtype that carries a higher mortality rate and is more common in women of African ancestry. ...

BU identifies contributors to high incidence of breast cancer in African-American women

August 16, 2011
Investigators from the Boston University's Slone Epidemiology Center have reported findings that may shed light on why African American women have a disproportionately higher risk of developing more aggressive and difficult-to-treat ...

New model better predicts breast cancer risk in African American women

January 26, 2015
Researchers from Boston University's Slone Epidemiology Center have developed a breast cancer risk prediction model for African- American women that found greater accuracy in predicting risk for the disease. The use of this ...

Recommended for you

Targeting the engine room of the cancer cell

June 18, 2018
Researchers at Columbia University Irving Medical Center (CUIMC) have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug ...

Study suggests well-known growth suppressor actually fuels lethal brain cancers

June 18, 2018
Scientists report finding a potentially promising treatment target for aggressive and deadly high-grade brain cancers like glioblastoma. But they also say the current lack of a drug that hits the molecular target keeps it ...

Researchers create novel combination as potential therapy for high-risk neuroblastoma

June 18, 2018
Researchers at VCU Massey Cancer Center in Richmond, Virginia, have identified a promising target to reverse the development of high-risk neuroblastoma and potentially inform the creation of novel combination therapies for ...

Genomics offers new treatment options for infants with range of soft tissue tumors

June 18, 2018
The genetic causes of a group of related infant cancers have been discovered by scientists at the Wellcome Sanger Institute, the University of Wuerzburg and their collaborators. Whole genome sequencing of tumours revealed ...

Standard myelofibrosis drug can awaken 'dormant' lymphoma

June 18, 2018
Most patients with myelofibrosis, a rare chronic disorder of the haematopoietic cells of the bone marrow, benefit from drugs from the JAK2 inhibitor class: symptoms are relieved, survival extended and general quality-of-life ...

Breast cancer researcher warns against online genetic tests

June 18, 2018
We have never been so fascinated by the secrets inside our cells.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.